IDA in Inflammatory Bowel Disease: Pathology, Treatment Options, and the Risks of Underdiagnosis.

This activity will discuss the unique clinical relationship between inflammatory bowel disease (IBD) and iron deficiency anemia (IDA), including the role IBD pathology plays in blocking optimal iron absorption. Many IBD patients contend with multiple challenges and comorbidities that all can directly or indirectly lead to IDA and subsequent poor outcomes. A leading gastroenterologist will discuss IDA-related diagnostic challenges, treatment options, and management protocols for IBD patients.

This activity is intended for gastroenterologists, hematologists, oncologists, and other healthcare professionals treating gastrointestinal and cancer related anemia.

Upon completion of this activity, participants will be able to:
• Define IDA etiology, signs/symptoms, and epidemiology across patient subsets.
• Outline established and novel treatment options for IDA, including efficacy, routes of administration, and clinical appropriateness for IDA across multiple patient subsets and clinical severity levels.
• Analyze clinical examples of IDA and develop feasible treatment solutions based on relevant symptom severity, practice setting, and patient subset.

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.